Covered recipient · General Payments record
PETER J MORIN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$18,911.66
- Reported across 539 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $872.50 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $222.12 | 14 |
| EMD Serono, Inc. | $149.81 | 2 |
| EISAI INC. | $125.00 | 1 |
| PFIZER INC. | $98.06 | 4 |
| Lundbeck LLC | $43.48 | 2 |
| ACADIA Pharmaceuticals Inc | $30.92 | 1 |
| Merz Pharmaceuticals, LLC | $30.42 | 1 |
| JAZZ PHARMACEUTICALS INC. | $28.01 | 1 |
| Amneal Pharmaceuticals LLC | $27.60 | 1 |
| GENZYME CORPORATION | $26.66 | 1 |
| Otsuka America Pharmaceutical, Inc. | $25.67 | 1 |
| Genentech USA, Inc. | $25.37 | 1 |
| Neurocrine BioSciences, Inc. | $23.29 | 1 |
| Lilly USA, LLC | $16.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.92 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105066472 | CMS |
| ABBVIE INC. | $18.14 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105066474 | CMS |
| ABBVIE INC. | $16.25 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105066476 | CMS |
| ABBVIE INC. | $16.45 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105066478 | CMS |
| ABBVIE INC. | $16.26 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105066480 | CMS |
| ABBVIE INC. | $23.60 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105066482 | CMS |
| ABBVIE INC. | $10.37 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105066484 | CMS |
| ABBVIE INC. | $11.65 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105066486 | CMS |
| ABBVIE INC. | $19.75 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105066488 | CMS |
| ABBVIE INC. | $16.25 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105066490 | CMS |
| ABBVIE INC. | $16.31 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105066492 | CMS |
| ABBVIE INC. | $9.32 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105066494 | CMS |
| ABBVIE INC. | $15.57 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105066496 | CMS |
| ABBVIE INC. | $12.28 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105066498 | CMS |
| ACADIA Pharmaceuticals Inc | $30.92 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147984752 | CMS |
| Amneal Pharmaceuticals LLC | $27.60 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139195884 | CMS |
| Eisai Inc. | $125.00 | 09/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110772999 | CMS |
| EMD Serono, Inc. | $29.81 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120211876 | CMS |
| EMD Serono, Inc. | $120.00 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120249439 | CMS |
| Genentech USA, Inc. | $25.37 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133088285 | CMS |
| GENZYME CORPORATION | $26.66 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139696424 | CMS |
| JAZZ PHARMACEUTICALS INC. | $28.01 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150220142 | CMS |
| Lilly USA, LLC | $16.09 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135278434 | CMS |
| Lundbeck LLC | $21.43 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145948242 | CMS |
| Lundbeck LLC | $22.05 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145948244 | CMS |
| Merz Pharmaceuticals, LLC | $30.42 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137953594 | CMS |
| Neurocrine Biosciences, Inc. | $23.29 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150845551 | CMS |
| Otsuka America Pharmaceutical, Inc. | $25.67 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118945767 | CMS |
| PFIZER INC. | $29.73 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131136724 | CMS |
| PFIZER INC. | $25.91 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131105023 | CMS |
| PFIZER INC. | $22.74 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131097934 | CMS |
| PFIZER INC. | $19.68 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131777422 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.